Becoming a Whistleblower, and exposing pharmaceutical fraud, helps ensure that drugs are only marketed for the uses for which they were approved.
- off-label marketing of drugs for uses other than those approved by the FDA;
- kickbacks and other inducements to physicians, hospitals and pharmacies to prescribe specific drugs;
- charging prices to the Government that are higher than allowable by law; and
- providing false or misleading data to the FDA during clinical research trials.
Pharmaceutical fraud settlements include:
- willfully paid illegal remuneration to physicians and other health care providers to induce them to purchase BMS drugs;
- knowingly promoted the sale and use of Abilify, an atypical antipsychotic drug, for pediatric use;
- set and maintained fraudulent and inflated prices for a wide assortment of oncology and generic drug products; and
- knowingly misreported the best price for the anti-depression drug, Serzone.
- failed to pay proper rebates to Medicaid and other government health care programs; and
- paid illegal remuneration to health care providers to induce them to prescribe the company’s products.